Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial

RCT (n=329) found dose of 4mg baricitinib in combination with background topical corticosteroids significantly improved signs and symptoms of moderate to severe atopic dermatitis at week 16 (IGA score clear/almost clear in 31%, 24% and 15% on 4mg, 2mg and placebo, respectively).

JAMA Dermatology